Biological Data Governance in an Age of AI with Doni Bloomfield

AI is unlocking new speed and power in biological research, creating opportunities for medical breakthroughs while raising new questions about oversight. This week, Elisa sits down with Doni Bloomfield, Associate Professor of Law at Fordham University, to discuss his recent report, Biological Data Governance in an Age of AI, and the growing risks of training AI models on sensitive viral and genetic information. Together, they explore how AI-powered virus research could shape future treatments, while examining the biosecurity risks of open scientific access and what thoughtful oversight might require.Doni Bloomfield is an Associate Professor of Law at Fordham Law School whose work focuses on intellectual property, biosecurity, national security law, and health law.References:Bloomfield, Doni et al. “Biological data governance in an age of AI.” Science (New York, N.Y.) vol. 391,6785 (2026): 558-561Turner, Stephen D. “Tiered Access for AIxBio Governance.” Paired Ends, 9 Feb. 2026.Amodei, Dario. “The Adolescence of Technology: Confronting and Overcoming the Risks of Powerful AI.” Dario Amodei, Jan. 2026.NIH All of Us Research ProgramThe White House. America’s AI Action Plan. Washington, DC: The White House, July 2025.Supreme Court of Alabama. Laurie Ibach and Mark Stewart v. Bruce Stewart, No. SC-2025-0106, Apr. 24, 2026.